Introduction / David M. Cutler and Alan M. Garber -- Reference pricing of pharmaceuticals for medicare: evidence from Germany, the Netherlands, and New Zealand / Patricia M. Danzon and Jonathan D. Ketcham -- Adverse selection and the challenges to stand-alone prescription drug insurance / Mark V. Pauly and Yuhui Zeng -- Disability forecasts and future medicare costs / Jayanta Bhattacharya [and others] -- Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter? / William H. Crown [and others] -- An economic analysis of health plan conversions: are they in the public interest? / Nancy Dean Beaulieu
Summary
This series from the NBER presents new research by leading economists on current health care policy issues. The papers in this seventh volume, originally presented at the annual Frontiers in Health Policy Research conference held in Washington D.C. in the summer of 2003, reflect the economic challenges faced by policymakers and health care professionals in an age of budget deficits. Topics discussed include prescription drug benefits as a stand-alone component of Medicare, disability rates and Medicare costs, and conversion to for-profit health plans
Analysis
ECONOMICS/Health Economics
SOCIAL SCIENCES/Political Science/Public Policy & Law
Notes
"National Bureau of Economic Research."
These papers were presented at the seventh annual Frontiers in Health Policy Research meeting held in Washington, D.C., in the summer of 2003
